79 related articles for article (PubMed ID: 20704685)
1. Melanoma stem cells--are there devils in the detail?
Shackleton M
Pigment Cell Melanoma Res; 2010 Oct; 23(5):693-4. PubMed ID: 20704685
[No Abstract] [Full Text] [Related]
2. Melanoma: do we need a hatchet or a scalpel?
Shackleton MJ; Quintana E; Fullen DR; Sabel MS; Johnson TM
Arch Dermatol; 2009 Mar; 145(3):307-8. PubMed ID: 19289763
[No Abstract] [Full Text] [Related]
3. Human malignant melanoma harbours a large fraction of highly clonogenic cells that do not express markers associated with cancer stem cells.
Prasmickaite L; Skrbo N; Høifødt HK; Suo Z; Engebråten O; Gullestad HP; Aamdal S; Fodstad Ø; Maelandsmo GM
Pigment Cell Melanoma Res; 2010 Jun; 23(3):449-51. PubMed ID: 20236249
[No Abstract] [Full Text] [Related]
4. Molecular markers of melanocytic tumor progression.
Weterman MA; van Muijen GN; Bloemers HP; Ruiter DJ
Lab Invest; 1994 May; 70(5):593-608. PubMed ID: 8196357
[No Abstract] [Full Text] [Related]
5. Spheres of influence in cancer stem cell biology.
Perego M; Alison MR; Mariani L; Rivoltini L; Castelli C
J Invest Dermatol; 2011 Feb; 131(2):546-7. PubMed ID: 20962857
[No Abstract] [Full Text] [Related]
6. Melanoma stem cells.
Roesch A
J Dtsch Dermatol Ges; 2015 Feb; 13(2):118-24. PubMed ID: 25631128
[TBL] [Abstract][Full Text] [Related]
7. Learning the ABCs of melanoma-initiating cells.
Zabierowski SE; Herlyn M
Cancer Cell; 2008 Mar; 13(3):185-7. PubMed ID: 18328422
[TBL] [Abstract][Full Text] [Related]
8. Is there a relationship between tissue inhibitor of metalloproteinase-1 and transforming growth factor-beta 1 with respect to malignant melanoma progression?
Kurdoglu M; Güllü IH; Akalin I
Med Hypotheses; 2001 Aug; 57(2):238-40. PubMed ID: 11461180
[TBL] [Abstract][Full Text] [Related]
9. Dipeptidyl peptidase II is not a marker for progression in melanoma.
Fröhlich E; Maier E; Mack AF; Garbe C
J Dermatol Sci; 2009 Jan; 53(1):68-71. PubMed ID: 18823758
[No Abstract] [Full Text] [Related]
10. Melanoma initiating cells - easy as ABC?
Bhoumik A; Ronai Z
Pigment Cell Melanoma Res; 2008 Apr; 21(2):111-2. PubMed ID: 18426402
[No Abstract] [Full Text] [Related]
11. Objective melanoma progression.
Rubegni P; Burroni M; Nami N; Cevenini G; Bono R; Sbano P; Fimiani M
Skin Res Technol; 2011 Feb; 17(1):69-74. PubMed ID: 20923468
[TBL] [Abstract][Full Text] [Related]
12. [S-100B and MIA (melanoma inhibiting activity) serum proteins: a prospective study of their value as melanoma progression markers].
Dornier C; Dousset B; Legras B; Barbaud A; Schmutz JL
Ann Dermatol Venereol; 2002 May; 129(5 Pt 1):739-40. PubMed ID: 12124520
[No Abstract] [Full Text] [Related]
13. Prognostic significance of the hair follicle stem cell marker nestin in patients with malignant melanoma.
Tanabe K; Amoh Y; Kanoh M; Takasu H; Sakai N; Sato Y; Katsuoka K
Eur J Dermatol; 2010; 20(3):283-8. PubMed ID: 20156773
[TBL] [Abstract][Full Text] [Related]
14. P75 nerve growth factor receptor staining is superior to S100 in identifying spindle cell and desmoplastic melanoma.
Lazova R; Tantcheva-Poor I; Sigal AC
J Am Acad Dermatol; 2010 Nov; 63(5):852-8. PubMed ID: 20950740
[TBL] [Abstract][Full Text] [Related]
15. NY-ESO-1 and CTp11 expression may correlate with stage of progression in melanoma.
Goydos JS; Patel M; Shih W
J Surg Res; 2001 Jun; 98(2):76-80. PubMed ID: 11397121
[TBL] [Abstract][Full Text] [Related]
16. Function association of tissue inhibitor of metalloproteinase-1 and malignant melanoma: systomics approach.
Wiwanitkit V
Acta Dermatovenerol Croat; 2010; 18(1):68. PubMed ID: 20361890
[No Abstract] [Full Text] [Related]
17. The significance of solid tumor stem cells in melanoma: Part 2.
Margolin KA
Curr Oncol Rep; 2008 Sep; 10(5):430. PubMed ID: 18706271
[No Abstract] [Full Text] [Related]
18. Angiopoietin-2 levels are associated with disease progression in metastatic malignant melanoma.
Helfrich I; Edler L; Sucker A; Thomas M; Christian S; Schadendorf D; Augustin HG
Clin Cancer Res; 2009 Feb; 15(4):1384-92. PubMed ID: 19228739
[TBL] [Abstract][Full Text] [Related]
19. Identification of melanoma initiating cells: does CD271 have a future?
Ballotti R
Future Oncol; 2015; 11(11):1587-90. PubMed ID: 26043212
[No Abstract] [Full Text] [Related]
20. Are circulating tumor cells an independent prognostic factor in patients with high-risk melanoma?
Hoon DS
Nat Clin Pract Oncol; 2004 Dec; 1(2):74-5. PubMed ID: 16264822
[No Abstract] [Full Text] [Related]
[Next] [New Search]
